Great to see this finally online! Excellent work by first author Kate to continue our studies in LASP1 in HPV+ cervical cancers. Thanks to all authors @oncovirusleeds.bsky.social Miao (Kate) Wang, Yigen Li, Molly Patterson, James Scarth #HPV #cervicalcancer
biorxiv.org/content/10.648…
Abstract submission deadline approaching fast (April 6th)!
RUNX1 aberrations in blast-phase CML induce the RBP SPATS2L which promotes growth, survival and stress granule assembly www.biorxiv.org/content/10.64898/2026.03...
RUNX1 aberrations in blast-phase CML induce the RBP SPATS2L which promotes growth, survival and stress granule assembly www.biorxiv.org/content/10.64898/2026.03...
Presenting our latest lab pre-print showcasing the research of Clinical PhD Fellow Dr David Palmer.
We discovered novel dysregulated RNA-binding proteins (RBP) downstream of RUNX1 aberrations in blast phase-CML, including SPATS2L, which promotes growth and survival.
www.biorxiv.org/content/10.6...
Delighted to share our latest work in @narjournal.bsky.social on the importance of (lnc)RNA–protein interactions in cell division, and how we identified RSRC2 as a new RBP involved in splicing and centrosome-associated RNA localisation
academic.oup.com/nar/article/...
Presenting the March 2026 WntUK newsletter!
Containing exciting information about our plans for the WntUK annual meeting being held across 16-17th November at the CRUK Scotland Institute.
Please send us your new WntUK papers, vacancies, and funding for inclusion in future editions!
Less than two weeks remain to apply for the new Research Fellow post in our group! 👇👇👇
🎉Proud to present our latest paper, out now in Nature Communications: www.nature.com/articles/s41...
RNA Binding Proteins (RBPs) are often full of intrinsically disordered regions (IDRs), but what these regions do during RNA recognition is often unclear. 1/10
#RNA #IDR #RBP
Join other cancer research students and early career researchers for a coffee, build a network, and connect with other researchers.
Multiple postdoctoral positions are available within the SCRC!
Check them out and apply before the upcoming deadlines.
sussexcancer.org/jobs
We're hiring a new 3 yr postdoc!
Join us for an exciting new CRUK funded project targeting RUNX1 mutations in CML in a highly supportive environment within @sussexbcr.bsky.social @biochembiomeduos.bsky.social @sussexcancer.org
Apply👇, advert closes 8th March.
jobs.sussex.ac.uk/job/4fee4e78...
Come join our lab in Sussex, UK for a PhD on TEs, on centromeres, on the genome ecosystem! Exciting times for TE:genome dynamics given the rate of T2T sequencing. Please circulate!
www.findaphd.com/phds/project...
Come and join our vibrant PhD community with a doctoral project now available in the lab of Dr @abousios.bsky.social 👇👇👇👇
Super strong representation from our department in SussexRNA at the RNA UK meeting in Windermere this week.
Many congrats to Jake, Courtney and Hope from the Ben Towler group, and Leandro Castellano, Lidia Vasilieva, Ben and Nikos for having abstracts accepted for presentation. 👏
We’re having a ball! 🕺 💃 🥂
Well actually it’s the Sussex Life Sciences ball but kindly organised by the @sussex.ac.uk Biomed Society.
6th March 7.30pm till late at Leonardo Royal, all students and staff welcome! Get your tickets before they sell out 👇👇👇👇
sussexstudent.com/events/id/4942…
Professor Claire Smith joins Peter and Jane Dick on This Morning, to explain why more people are choosing to donate their bodies to science - and what it means for medical training and research.
Watch here: www.youtube.com/watch?v=aZEu...
We are hiring! We are looking for a Laboratory Scientific Officer to join our new group at The Cyprus Institute of Neurology & Genetics.
Please share and feel free to message me for further details. The link for the advert is below
cing.ac.cy/en/vacancies...
We also have a PhD project available in the Tumour Virology group at The Cyprus Institute of Neurology and Genetics.
Please feel free to contact me for further details.
www.cing.ac.cy/education
😜 coming soon....
Advert to follow shortly for a 3 year Research Fellow to lead on the project which begins May 1st.
@sussexbcr.bsky.social @sussexcancer.org @sussex.ac.uk @biochembiomeduos.bsky.social
5/5
Many thanks also to Co-Investigators Dr Sophie Kellaway from @uniofnottingham.bsky.social and Dr Fabio Simoes from @bsmsmedschool.bsky.social and collaborators at @glasgow.ac.uk Gillian Horne Mhairi Copland for helping put the application together and supporting the study.
4/5
RUNX1 is an important transcription factor frequently mutated in blood cancer for which no satisfactory targeted treatments exist currently.
David has made some new and exciting discoveries around RUNX1 biology that will be exploited for leukaemia treatment in this study.
3/5
The study builds on the incredibly exciting findings from our Clinical PhD Fellow Dr David Palmer over the past 3 years.
David is a phenomenally talented Haematology Registrar from @uhsussex.bsky.social who started his Clinician Scientist journey with us in 2023.
2/5
Beyond pleased to announce our lab has secured its first @cancerresearchuk.org funding with an Early Detection & Diagnosis Project Award titled:
'Detecting and targeting translation inhibitor sensitive RUNX1 mutations in Chronic Myeloid Leukaemia'
1/5
www.cancerresearchuk.org/for-research...
🔔New network opportunity!🔔
Prof @mitchell.science at @bsmsmedschool.bsky.social is advertising a new 3yr @leukaemiauk.bsky.social funded PDRA using mechanistic models to identify B-cell lymphoma therapeutic vulnerabilities.
Expected start date: April’26
Apply👇by 01/03/2026 and join Sussex BCR!
Huge congratulations to brand new Dr Jo Renaut from the Frances Pearl lab at @sussex.ac.uk who successfully defended her PhD thesis titled ‘Exploiting cancer vulnerabilities: A predictive approach to synthetic lethality via dependency mapping and metabolic disruption.’ 👏🎓👊
Very cool paper, on my reading list! We were desperate to get hold of some primary JMML samples for this very reason but not a resource widely available in the UK.
We'd be very interested in hearing more about this. Perhaps we could talk more offline?
Thanks Mark, we think so too although of course a little biased. Hopefully the field agrees!
LIN28B is a fascinating RBP in the haematopoietic system.
We’re excited to announce that we’re looking for a postdoctoral research to join our team!
This is an opportunity to lead an exciting project aiming to push the boundaries of personalised medicine through integrating data, simulation and lab experiments.
Plz share
mitchell.science/talk/we-are-...